Today ASCO 2020 kicks off in earnest with the Presidential address, followed by highlights in breast, head and neck, and gastrointestinal cancers. It follows our live coverage of ASCO 2020 day 1 ...
The trial recruited 112 patients across 23 UK cancer centres. Many scientists from The Institute of Cancer Research, London are attending the virtual 2020 ASCO conference. See all of our news and blog ...
Many scientists from The Institute of Cancer Research, London are attending the virtual 2020 ASCO conference. See all of our news and blog posts from the event. The team looked at more than a thousand ...
This year, Trump managed to win back a few states that he lost in 2020 but won in 2016, when he punctured the Democratic "blue wall" and claimed the presidency. Projected victories in North ...
Medscape Oncology, July 2020 Practice-Changing GI Cancer Highlights From Virtual ASCO 2020 Gastrointestinal cancer expert Dr John Marshall gives his high-level overview of the most important ...
Nazli Dizman, MD, discussed the current measures for enforcing ASCO’s language of respect guidelines in the renal cell ...
Nat Geo’s 21 most compelling images of the 21st century Nat Geo’s 21 most compelling images of the 21st century These are our best animal photos of 2020 These are our best animal photos of ...
3 To achieve that, ASCO launched the QOPI for low- and middle-income country (LMIC) pilot program in 2020. This manuscript will describe the QOPI for the LMIC program and share the experience of ...
Obe-cel was designed to increase T-cell persistence and reduce T-cell exhaustion and was shown to improve response rates and survival, particularly in patients with low leukemia burden.
Tracking the state of the race between President Donald Trump and his Democratic rival Joe Biden, updated as polls are released. The NBC News National Polling Average is based on an unweighted ...
Founded in 1968, Jayco is advertised as “America’s Most Livable RVs” and furnishes the marketplace with an extensive range of portable, family recreational products. Starting their long-continuing ...
It follows our live coverage of ASCO 2020 day 1 and day 2, during which we’ve already featured Amgen’s Kyprolis, AstraZeneca’s Tagrisso, rare cancers and genomics, BCMA therapy, COVID-19’s ...